Cancer Research
New biomarker improves early lung cancer detection
October 04, 2025 Hoton da AI ya samar
Researchers have identified a novel protein biomarker that detects lung cancer at an early stage with high accuracy. The discovery, detailed in a recent study, could enhance screening methods and improve patient outcomes. Clinical trials showed promising results in identifying the disease before symptoms appear.
Researchers develop AI tool for early cancer detection
September 29, 2025 An Ruwaito ta hanyar AI
Scientists have unveiled a new artificial intelligence model that improves early detection of lung cancer from CT scans. The tool, trained on thousands of images, achieves higher accuracy than traditional methods. This advancement could significantly boost survival rates for patients.
Summit's Lung Cancer Drug Shows Promise
September 09, 2025 An Ruwaito ta hanyar AI
Biotech company Summit announced promising results from its lung cancer drug in recent trials. The drug demonstrated potential efficacy in treating advanced cases, marking a step forward in oncology treatments. Further studies are planned to confirm these findings.
Bacteria in tumors produce molecule to boost cancer chemotherapy
Scientists have identified a molecule produced by bacteria inside tumors that enhances the effectiveness of chemotherapy against colorectal cancer. The compound, 2-methylisocitrate, damages cancer cell DNA and disrupts their metabolism. This discovery could lead to new treatments that make existing drugs more potent.
DNA scar catalog opens paths to overcome cancer drug resistances
Researchers at Spain's National Cancer Research Centre (CNIO) have developed a comprehensive catalog of mutational 'scars' in DNA caused by cancer. This breakthrough, published in Nature, could help bypass resistances to treatments like PARP inhibitors. The study analyzes thousands of tumor samples to identify key genetic patterns.